首页> 外文期刊>Critical reviews in oncology/hematology >Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians
【24h】

Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians

机译:癌症患者的多立糖酶抑制剂诱导的肝损伤:临床医生综述

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Multikinase inhibitors (MKI) are targeted molecular agents that have revolutionized cancer management. However, there is a paucity of data concerning MKI-related liver injury risk and clinical guidelines for the management of liver toxicity in patients receiving MKI for cancer are scarce.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号